[Mechanisms of resistance to DNA topoisomerase II inhibitors]
- PMID: 1651684
[Mechanisms of resistance to DNA topoisomerase II inhibitors]
Abstract
Cytotoxicity of anticancer drugs are depended on cellular differences of drug transport processes, drug metabolism or proliferation process including DNA synthesis. Thus, resistance to anticancer drugs is likely due to many cellular changes. Mechanisms of resistance to anticancer drugs have been studied with cells selected for their ability to grow in the presence of drugs. In this paper, the mechanisms of cellular resistance to DNA topoisomerase II inhibitors was described.
Similar articles
-
Mechanisms of resistance to drugs that inhibit DNA topoisomerases.Semin Cancer Biol. 1991 Aug;2(4):235-44. Semin Cancer Biol. 1991. PMID: 1655118 Review.
-
DNA breakage in human lung carcinoma cells and nuclei that are naturally sensitive or resistant to etoposide and teniposide.Cancer Res. 1986 Aug;46(8):3809-16. Cancer Res. 1986. PMID: 3015377
-
Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide).Cancer Res. 1989 Nov 15;49(22):6202-7. Cancer Res. 1989. PMID: 2553248
-
DNA topoisomerase: the mechanism of resistance to DNA topoisomerase II inhibitor VP-16.Hiroshima J Med Sci. 1989 Dec;38(4):197-207. Hiroshima J Med Sci. 1989. PMID: 2561562
-
[Poisons of DNA topoisomerases I and II].Bull Cancer. 1993 Nov;80(11):923-54. Bull Cancer. 1993. PMID: 8081034 Review. French.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources